Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy

Tools

Item Type:	Article
Title:	Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy
Creators Name:	Schneider, V., Zhang, L., Bullinger, L., Rojewski, M., Hofmann, S., Wiesneth, M., Schrezenmeier, H., Götz, M., Botzenhardt, U., Barth, T.F.E., Döhner, K., Döhner, H. and Greiner, J.
Keywords:	Acute Myeloid Leukemia, ADP-ribosyl Cyclase 1, CD Antigens, CD34 Antigens, Immunotherapy, Interleukin-12, Interleukin-12 Receptors, Mutation, Neoplastic Stem Cells, Nuclear Proteins, Nucleophosmin
Source:	Leukemia
ISSN:	0887-6924
Publisher:	Nature Publishing Group
Volume:	28
Number:	8
Page Range:	1759-62
Date:	August 2014
Official Publication:	https://doi.org/10.1038/leu.2014.116
PubMed:	View item in PubMed

Repository Staff Only: item control page